Home
Innovative medicines pipeline
ColiFin®
Inhaled Murepavadin
Balixafortide (POL6326)
OMPTA – new antibiotics
EBX-002
POL6014 (Lonodelestat)
Pharma collaborations
About us
Investor Relations
Corporate Governance*
Reporting*
Corporate Presentation
Share Information
Media Releases
Ad-hoc Releases
Calendar
Contact
Careers
Contact
Home
Innovative medicines pipeline
ColiFin®
Inhaled Murepavadin
Balixafortide (POL6326)
OMPTA – new antibiotics
EBX-002
POL6014 (Lonodelestat)
Pharma collaborations
About us
Investor Relations
Corporate Governance*
Reporting*
Corporate Presentation
Share Information
Media Releases
Ad-hoc Releases
Calendar
Contact
Careers
Contact
News
Menu
Home
Innovative medicines pipeline
ColiFin®
Inhaled Murepavadin
Balixafortide (POL6326)
OMPTA – new antibiotics
EBX-002
POL6014 (Lonodelestat)
Pharma collaborations
About us
Investor Relations
Corporate Governance*
Reporting*
Corporate Presentation
Share Information
Media Releases
Ad-hoc Releases
Calendar
Contact
Careers
Contact
News
Menu
IPO Information
Spexis
>
IPO Information
This site uses cookies:
Find out more.
Accept